Identification of Akt1 as a potent therapeutic target for oral squamous cell carcinoma

By Nakashiro Koh-Ichi   Tanaka Hiroshi   Goda Hiroyuki   Iwamoto Kazuki   Tokuzen Norihiko   Hara Shingo   Onodera Jun   Fujimoto Ichiro   Hino Satoshi   Hamakawa Hiroyuki  

International Journal of Oncology, Vol. 47, Iss. 4, 2015-10 ,pp. : 1273-1281

Spandidos Publications

Access to resources Recommend Favorite

Multifunctional properties of RANKL/RANK in cell differentiation, proliferation and metastasis

By Kukita Akiko   Kukita Toshio  

Future Oncology, Vol. 9, Iss. 11, 2013-11 ,pp. : 1609-1622

Future Medicine

Access to resources Recommend Favorite

Receptor activator of nuclear factor-κB ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissues (Review)

By    

Molecular Medicine Reports, Vol. 11, Iss. 5, 2015-01 ,pp. : 3212-3218

Spandidos Publications

Access to resources Recommend Favorite

Role of FGF receptors as an emerging therapeutic target in lung squamous cell carcinoma

By Lim Sun Min   Kim Hye Ryun   Shim Hyo Sup   Soo Ross A   Cho Byoung Chul  

Future Oncology, Vol. 9, Iss. 3, 2013-03 ,pp. : 377-386

Future Medicine

Access to resources Recommend Favorite

Integrin alpha 6: A novel therapeutic target in esophageal squamous cell carcinoma

By Kwon Junhye   Lee Tae-Sup   Lee Hae Won   Kang Moon Chul   Yoon Hyeon-Joon   Kim Ji-Hee   Park Jong Ho  

International Journal of Oncology, Vol. 43, Iss. 5, 2013-11 ,pp. : 1523-1530

Spandidos Publications

Access to resources Recommend Favorite